Clinical trials in developing countries: risk or opportunity?
نویسندگان
چکیده
منابع مشابه
European & Developing Countries Clinical Trials Partnership (EDCTP)
EDCTP was established by the European Union in 2003. The first EDCTP program ran until 2015 and focused on HIV, tuberculosis (TB) and malaria. It supported numerous clinical trials that aimed to have a significant impact on the diagnosis, treatment and prevention of these diseases. In light of significant unmet medical needs, the scope of EDCTP was extended in 2014, now covering neglected infec...
متن کاملTrials in developing countries.
Good clinical trials can be carried out in the developing countries but ethical issues concerning the trials are frequently brought up for international debate. The concern has its own merit but can be amended if investigators (local and international) pay serious attention to these criticisms and work out the way that will most benefit the trial participants. Although scientific progress is im...
متن کاملEthical issues in clinical trials in developing countries.
The vertical transmission trials conducted in a variety of developing countries by researchers from more developed countries illustrate a variety of crucial ethical issues. Three crucial issues are the injustice of the use of placebo control groups, the coerciveness of the offer to participate, and the exploitation of Third World countries. This paper examines each of these issues separately. I...
متن کاملRandomised trials in developing countries
Professor Trevor Duke and colleagues at the Centre for International Child Health, University of Melbourne, have made a remarkable contribution to international child health. Over the past 11 years, they have undertaken annual structured searches for published reports of controlled trials of interventions addressing child health in developing countries, and assembled summaries in a compendium t...
متن کاملPatient-Funded Trials: Opportunity or Liability?
Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Future Medicinal Chemistry
سال: 2009
ISSN: 1756-8919,1756-8927
DOI: 10.4155/fmc.09.103